Updated Date:
30 Oct 2026
Product Detail:
APO-TOPIRAMATE topiramate 25 mg tablet blister pack
Shortage Status:
Current
AUST R:
124729
Availability:
Limited Availability
Active Ingredient:
topiramate
Reason:
Commercial Changes / Commercial viability
Dosage Form:
Tablet,filmcoated
Supply Impact Dates
From 03 Sep 2026 To 09 Apr 2027
Management Action:
Alternative brands are available. An overseas-registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: www.tga.gov.au/resources/section-19a-approvals